Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium plantarum

What does the research say about Bifidobacterium plantarum?

14 health outcomes synthesised

Research on Bifidobacterium plantarum spans 12 health outcomes, with the strongest evidence supporting improved quality of life (moderate evidence from 3 studies). The most robust effect is a moderate improvement in adult IBS patients, while effects in dermatological conditions are small. No consistent effective dose or form has been identified across studies.

Strongest evidence: The only outcome with moderate evidence strength is Improved Quality of Life, based on 3 studies (including one meta-analysis). Effects were moderate in adult IBS patients and small in individuals with psoriasis or atopic dermatitis. No dose or form data were reported.

Mixed or weaker evidence: Eleven outcomes have low or very low evidence. For Reduced Inflammation (8 studies, low evidence), one meta-analysis in athletes showed a moderate reduction in TNF-α (ES –0.59). Improved Cognitive Function (7 studies, low evidence) showed small improvements on the MMSE and MoCA, and a large effect on depressive symptoms. Reduced Depression Symptoms (3 studies, low evidence) showed moderate effects (SMD –0.55) but mostly from multi-strain formulations. Other outcomes – including gut microbiota balance, SCFA production, immune modulation, and gastrointestinal health – rely entirely on narrative reviews or animal/in vitro work, with no statistically significant findings.

Effective dose patterns: No consistent dose or form was reported across any outcome. All syntheses list effectiveDose as null, indicating that the available research does not provide a reliable dose range for Bifidobacterium plantarum.

Population insights: The only clear population pattern emerges for quality of life (adult IBS patients) and inflammation (athletes). Most other studies involve heterogeneous groups (e.g., adults with depression, CKD patients, livestock) or do not specify populations. No cross-cutting demographic insights (e.g., age or deficiency) are supported by the data.

Notable caveats: The vast majority of evidence comes from narrative reviews or meta-analyses of multi-strain probiotics, making it difficult to isolate the effect of Bifidobacterium plantarum alone. Many reviews lack original clinical data, and sample sizes are often small. None of the syntheses provide dose or duration data, limiting practical interpretation.

Frequently asked

  • What is Bifidobacterium plantarum good for according to research?
    The strongest research (moderate evidence) supports its use for improving quality of life, particularly in adults with IBS. Other outcomes such as reducing inflammation, improving cognitive function, and reducing depression symptoms show low evidence of benefit, but findings come from limited or multi-strain studies.
  • What dose of Bifidobacterium plantarum is typically used in studies?
    No consistent effective dose has been reported across the 12 research syntheses. Most studies did not report dose data, and those that did used multi-strain formulations, making it impossible to isolate a specific dose for Bifidobacterium plantarum alone.
  • Who benefits most from Bifidobacterium plantarum?
    The clearest population benefit is seen in adults with IBS, where moderate improvements in quality of life were observed. Athletes also showed a moderate reduction in inflammation in one meta-analysis. Other populations (e.g., individuals with depression, dermatological conditions, or mild cognitive impairment) are supported only by low-evidence studies.
  • Are there caveats or limitations in the research on Bifidobacterium plantarum?
    Yes. Most evidence comes from narrative reviews or multi-strain probiotic studies, not from original clinical trials focusing solely on Bifidobacterium plantarum. Many studies have small sample sizes, lack statistical significance, and do not report dose or duration. Only one outcome (quality of life) has moderate evidence strength; all others are low or very low.
  • Does Bifidobacterium plantarum help with depression?
    Three studies (all low evidence) report moderate beneficial effects on depression symptoms, including a meta-analysis showing a significant reduction (SMD –0.55). However, the evidence is limited to multi-species formulations and systematic reviews; no original human RCTs isolate Bifidobacterium plantarum's effect.
  • Does Bifidobacterium plantarum reduce inflammation?
    Eight studies (low evidence) show moderate reductions in inflammation, but only one meta-analysis in athletes reached statistical significance (TNF-α reduction). Most evidence comes from reviews and animal studies, and human data are limited to specific populations like athletes. No dose information is available.

Most-studied combinations with Bifidobacterium plantarum

most supplement research is combination research
Also studied with:Lactobacillus rhamnosus (3), Bifidobacterium lactis UABla-12 (2), Lactobacillus casei rhamnosus (2), Lactobacillus acidophilus LA-02 (2), Lactobacillus rhamnosus HA-500 (2), Lactobacillus rhamnosus HA-114 (2), Bifidobacterium bifidum Rosell-71 (2), Fermented Soy Probiotic (2), Lactobacillus plantarum LP01 (2), Lactobacillus helveticus Rosell-52 (2), Lactobacillus lactis LI-23 (2), Bifidobacterium lactis Bb-02 (2)

  • LactoBif 100 Probiotics

    By California Gold Nutrition

    4.7 (17.7K reviews)
    Out of Stock
    Best Price Guarantee
    Prices from Different Sellers
    Prices from Different Sellers
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.35
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top